TGA approves next generation diabetes drug Mounjaro

Will Eli Lilly’s potential blockbuster get the same social media weight-loss attention as shortage plagued Ozempic? The next generation of Type-2 diabetes drugs – and by extension weight-loss drugs – is now firmly with us with the TGA’s decision just before Christmas to approve Eli Lilly’s much-anticipated Mounjaro for use for Type-2 diabetes. That listing,